|
|
|
|
|
Lung Cancer Screening & Treatment After COVID-19
|
|
June 10, 2021 • 6:30pm ET
|
|
|
Objectives:
Recent research and trends into lung cancer screening The clinical impact of lacking screening The effect of COVID-19 on lung cancer screening The US Preventive Services Task Force 2021 Lung Cancer Screening Guidelines: key takeaways, what’s new, etc.
|
|
|
|
|
|
|
Albert Rizzo, MD, FCCP FACP FAASM
Chief Medical Officer
American Lung Association
Clinical Asst. Professor of Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, PA
|
|
|
James L. Mulshine, MD
Professor, Internal Medicine
Associate Director, Institute of Translation Medicine
Rush University
Chicago, Il
|
|
|
Sandip Patel, MD
Associate Professor
Medical Oncology
UC San Diego
San Diego, CA
|
|
|
Jacob Sands, MD
Physician, Dana-Farber Cancer Institute
Instructor of Medicine, Harvard Medical School
Andrea Borondy Kitts
Boston, MA
|
|
|
Andrea Borondy Kitts
Lung Cancer and Patient Advocate
Rescue Lung Society
Amesbury, MA
|
|
|
M. Patricia Rivera, MD
Professor of Medicine
The University of North Carolina at Chapel Hill
Chapel Hill, NC
|
|
|
|
|
|
|
|
|
|
|
